Riyaz Bashir, TCT 2022: The Bashir endovascular catheter in patients with acute intermediate risk pulmonary embolism, the RESCUE study
The RESCUE study examined the Bashir endovascular catheter in patients with acute intermediate risk pulmonary embolism (PE). In this touchCARDIO interview, we speak with Dr Riyaz Bashir (Temple University Hospital, Philadelphia, PA, USA) to discuss the RESCUE study and future plans.
The abstract entitled ‘A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
- What were the aims, design and eligibility criteria of the RESCUE study? (0:23)
- What were the efficacy and safety findings of the study? (2:06)
- What questions remain unanswered regarding the use of this catheter, and what further studies are planned? (3:17)
Disclosures: Riyaz Bashir is on the advisory board and speaker’s bureau for Thrombolex Inc. and a consultant for the company. He has received honorarium and grant/research support from Thrombolex Inc. and is a major stock shareholder.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Devices here
Share this Video
Related Videos In Devices
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Andrew Krahn: Heart Rhythm 2023 & HRX 2023 – The latest Innovations in arrhythmia care and technology
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization dedicated to improving the care of patients with heart rhythm disorders […]
Steven Messe, TCT 2022: Sentinel® cerebral protection system efficacy in reducing all stroke/disabling stroke, the PROTECTED-TAVR trial (a neurologist’s perspective)
The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University of Pennsylvania, Philadelphia, PA, USA) to give a Neurologist’s perspective on the findings of the PROTECTED-TAVR […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!